Venetoclax Combined with FLAG-IDA Induction and Consolidation in Newly Diagnosed Acute Myeloid Leukemia

被引：0
|
作者：
Lachowiez, Curtis [1 ]
Takahashi, Koichi [2 ]
Loghavi, Sanam [3 ]
Xiao, Lianchun [4 ]
Kadia, Tapan [2 ]
Adeoti, Maria [2 ]
Short, Nicholas [2 ]
Sasaki, Koji [2 ]
Wang, Sa [3 ]
Borthakur, Gautam [2 ]
Issa, Ghayas [2 ]
Maiti, Abhishek [2 ]
Alvarado, Yesid [2 ]
Pemmaraju, Naveen [2 ]
Bravo, Guillermo Montalban [2 ]
Masarova, Lucia [2 ]
Yilmaz, Musa [2 ]
Jain, Nitin [2 ]
Andreeff, Michael [2 ]
Jabbour, Elias [2 ]
Garcia-Manero, Guillermo [2 ]
Kornblau, Steven [2 ]
Ravandi, Farhad [2 ]
Konopleva, Marina [2 ]
Kantarjian, Hagop [2 ]
DiNardo, Courtney [2 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2021年 / 21卷
关键词：
induction chemotherapy; venetoclax; targeted therapy; acute myeloid leukemia;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
AML-204
引用
收藏
页码：S291 / S291
页数：1
相关论文
共 50 条
  • [31] A Prognostic Index for Patients with Refractory or in First Relapsed Acute Myeloid Leukemia Treated with FLAG-Ida or Flago-Ida
    Miguel Bergua, Juan
    Montesinos, Pau
    Martinez-Cuadron, David
    Fernandez-Abellan, Pascual
    Serrano, Josefina
    Jose Sayas, Maria
    Prieto-Fernandez, Julio
    Garcia, Raimundo
    Julia Garcia-Huerta, Ana
    Barrios, Manuel
    Perez-Lopez, Cristina
    Perez-Encinas, Manuel
    Siemele, Adriana
    Rodriguez-Macias, Gabriela
    Herrera-Puente, Pilar
    Rodriguez-Veiga, Rebeca
    Pilar Martinez-Sanchez, Maria
    Lourdes Amador-Barciela, Maria
    Sanz, Miguel A.
    BLOOD, 2014, 124 (21)
  • [32] A Phase Ib/II Study of the BCL-2 Inhibitor Venetoclax in Combination with Standard Intensive AML Induction/Consolidation Therapy with FLAG-IDA in Patients with Newly Diagnosed or Relapsed/Refractory AML
    Aboudalle, Iman
    Konopleva, Marina Y.
    Kadia, Tapan M.
    Naqvi, Kiran
    Vaughan, Kenneth
    Kurt, Mehmet
    Cavazos, Antonio
    Pierce, Sherry A.
    Takahashi, Koichi
    Masarova, Lucia
    Yilmaz, Musa E.
    Jabbour, Elias
    Garcia-Manero, Guillermo
    Kornblau, Steven M.
    Ravandi, Farhad
    Cortes, Jorge
    Kantarjian, Hagop M.
    DiNardo, Courtney D.
    BLOOD, 2019, 134
  • [33] DECITABINE COMBINED WITH HAAG AS INDUCTION CHEMOTHERAPY FOR NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA
    Tang, X.
    Cui, W.
    Jin, Z.
    Cao, J.
    Guo, D.
    Sun, A.
    Zhu, X.
    Qiu, H.
    Fu, C.
    Han, Y.
    Ruan, C.
    Wu, D.
    HAEMATOLOGICA, 2016, 101 : 383 - 384
  • [34] FLAG-IDA in the treatment of refractory/relapsed adult acute lymphoblastic leukemia
    Specchia, G
    Pastore, D
    Carluccio, P
    Liso, A
    Mestice, A
    Rizzi, R
    Ciuffreda, L
    Pietrantuono, G
    Liso, V
    ANNALS OF HEMATOLOGY, 2005, 84 (12) : 792 - 795
  • [35] Treatment of Adverse-Risk and Refractory/Relapsed Acute Myeloid Leukemia (AML) Patients with FLAG-IDA ± Venetoclax and CLAG-M: A Monocentric Experience
    Rahme, Ramy
    Vidal, Valerie
    Hueso, Thomas
    Le Meur, Lucie
    Rigal, Marthe
    Ivanoff, Sarah
    Brechignac, Sabine
    De latour, Regis Peffault
    Gardin, Claude
    Braun, Thorsten
    BLOOD, 2023, 142
  • [36] Retrospective Comparison between MEC and FLAG-Ida Regimens for Refractory or Relapsed Acute Myeloid Leukemia in Adults
    Silva, Wellington F.
    Da Rosa, Lidiane Ines
    Seguro, Fernanda S.
    Silveira, Douglas R. A.
    Nardinelli, Luciana
    Buccheri, Valeria
    Velloso, Elvira D. R. P.
    Rocha, Vanderson
    Rego, Eduardo M.
    BLOOD, 2019, 134
  • [37] Use of FLAG plus Venetoclax As Consolidation/Bridge to HSCT in Patients with Acute Myeloid Leukemia
    Ananthula, Aneesha
    Manogna, Dharmini
    Lanka, Sree
    Thomas, Katharine
    Safah, Hana
    Saba, Nakhle S.
    Socola, Francisco
    BLOOD, 2022, 140 : 11734 - 11735
  • [38] FLAG-IDA IN THE TREATMENT OF ACUTE LEUKEMIA: SINGLE-CENTER EXPERIENCE
    Goyanes Martin, M. I.
    Canales Albendea, M. A.
    Fabra Urdiola, M.
    Meijon Ortigueira, M. D. M.
    Jimenez Yuste, V.
    HAEMATOLOGICA, 2017, 102 : 682 - 682
  • [39] FLAG-IDA in the treatment of refractory/relapsed adult acute lymphoblastic leukemia
    G. Specchia
    D. Pastore
    P. Carluccio
    A. Liso
    A. Mestice
    R. Rizzi
    L. Ciuffreda
    G. Pietrantuono
    V. Liso
    Annals of Hematology, 2005, 84 : 792 - 795
  • [40] Low-Dose IA with Venetoclax Regimen As Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia
    Zheng, Weiyan
    BLOOD, 2023, 142
12345